✦ LIBER ✦

Single-agent therapy with oral mercaptopurine for nonlymphoid blast crisis of chronic myeloid leukemia

✍ Scribed by J.-C. Hernández-Boluda; F. Cervantes; A. Alvarez; D. Costa; E. Montserrat

Book ID: 105990610
Publisher: Springer
Year: 2001
Tongue: English
Weight: 41 KB
Volume: 80
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s002770100336

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapy-related acute myeloid leukemia a

✍ Clarence C.K. Lam; Edmond S.K. Ma; Yok-Lam Kwong 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB 👁 2 views

Therapy of refractory/relapsed acute mye

Therapy of refractory/relapsed acute myeloid leukemia and blast crisis of chronic myeloid leukemia with the combination of cytosine arabinoside, tetrahydrouridine, and carboplatin

✍ Jonathan H. Marsh; Willi Kreis; Barbara Barile; Silvia Akerman; Philip Schulman; 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 428 KB

Imatinib combined with mitoxantrone/etop

Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis

✍ Stefan Fruehauf; Julian Topaly; Eike C. Buss; Thomas Fischer; Oliver G. Ottmann; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 1 views

Standard-dose imatinib plus low-dose hom

Standard-dose imatinib plus low-dose homoharringtonine and granulocyte colony-stimulating factor is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis who have failed prior single-agent therapy with imatinib

✍ Baijun Fang; Ning Li; Yongping Song; Qin Han; Robert Chunhua Zhao 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 127 KB

Allogeneic hematopoietic stem cell trans

Allogeneic hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in second chronic phase attained by imatinib after onset of blast crisis

✍ Ying Wang; Depei Wu; Aining Sun; Zhengming Jin; Huiying Qiu; Miao Miao; Xiaowen 📂 Article 📅 2008 🏛 Carden Jennings Publishing 🌐 English ⚖ 160 KB

High-dose imatinib mesylate combined wit

High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia

✍ Rea, D; Legros, L; Raffoux, E; Thomas, X; Turlure, P; Maury, S; Dupriez, B; Pign 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 100 KB